XML 129 R2.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Income (Loss) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
[1]
Jun. 30, 2022
Jun. 30, 2021
[1]
Income Statement [Abstract]        
Net sales $ 254,151 $ 264,483 $ 494,326 $ 512,086
Cost of sales 69,801 92,204 141,533 176,399
Gross profit 184,350 172,279 352,793 335,687
Operating expenses:        
Selling, general and administrative 116,482 122,748 235,007 238,429
Research and development 34,229 52,557 75,147 97,182
Other operating expenses 1,883 33,236 1,378 42,036
Operating income (loss) 31,756 (36,262) 41,261 (41,960)
Interest expense (14,388) (16,515) (22,228) (32,451)
Foreign exchange and other income/(expense) 1,633 239 5,537 (6,204)
Income (loss) before tax 19,001 (52,538) 24,570 (80,615)
Income tax expense 2,515 3,908 5,052 6,552
Losses from equity method investments (42) (41) (81) (81)
Net income (loss) $ 16,444 $ (56,487) [2] $ 19,437 $ (87,248) [2],[3]
Basic loss per share (in dollars per share) $ 0.31 $ (1.15) $ 0.36 $ (1.79)
Diluted loss per share (in dollars per share) $ 0.30 $ (1.15) $ 0.36 $ (1.79)
Shares used in computing basic loss per share (in shares) 53,506 48,928 53,420 48,833
Shares used in computing diluted loss per share (in shares) 54,080 48,928 54,144 48,833
[1] The condensed consolidated statements of income (loss) for the three and six months ended June 30, 2021 have been revised. For further details refer to “Note 1. Unaudited Condensed Consolidated Financial Statements.”
[2] The condensed consolidated statements of comprehensive income (loss) for the three and six months ended June 30, 2021 have been revised. For further details refer to “Note 1. Unaudited Condensed Consolidated Financial Statements.”
[3] The condensed consolidated statement of cash flows for the three and six months ended June 30, 2021 have been revised. For further details refer to “Note 1. Unaudited Condensed Consolidated Financial Statements.”